131 related articles for article (PubMed ID: 25304235)
1. Driver KIT mutations in melanoma cluster in four hotspots.
Dumaz N; André J; Sadoux A; Laugier F; Podgorniak MP; Mourah S; Lebbé C
Melanoma Res; 2015 Feb; 25(1):88-90. PubMed ID: 25304235
[TBL] [Abstract][Full Text] [Related]
2. KIT gene mutations and copy number in melanoma subtypes.
Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
[TBL] [Abstract][Full Text] [Related]
3. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
[TBL] [Abstract][Full Text] [Related]
4. Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report.
Rapisuwon S; Parks K; Al-Refaie W; Atkins MB
Melanoma Res; 2014 Oct; 24(5):509-11. PubMed ID: 25003536
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations.
Schoenewolf NL; Bull C; Belloni B; Holzmann D; Tonolla S; Lang R; Mihic-Probst D; Andres C; Dummer R
Eur J Cancer; 2012 Aug; 48(12):1842-52. PubMed ID: 22464346
[TBL] [Abstract][Full Text] [Related]
6. Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.
Vita M; Tisserand JC; Chauvot de Beauchêne I; Panel N; Tchertanov L; Agopian J; Mescam-Mancini L; Fouet B; Fournier B; Dubreuil P; Bertucci F; De Sepulveda P
JAMA Dermatol; 2014 Dec; 150(12):1345-9. PubMed ID: 25317746
[TBL] [Abstract][Full Text] [Related]
7. KIT in melanoma: many shades of gray.
Slipicevic A; Herlyn M
J Invest Dermatol; 2015 Feb; 135(2):337-338. PubMed ID: 25573046
[TBL] [Abstract][Full Text] [Related]
8. [New therapies targeting the genetic mutations responsible for different types of melanoma].
Botella-Estrada R; Sanmartín Jiménez O
Actas Dermosifiliogr; 2010 Jun; 101(5):394-400. PubMed ID: 20525481
[TBL] [Abstract][Full Text] [Related]
9. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.
Posch C; Moslehi H; Sanlorenzo M; Green G; Vujic I; Panzer-Grümayer R; Rappersberger K; Ortiz-Urda S
Oncotarget; 2016 Jul; 7(29):45916-45925. PubMed ID: 27322141
[TBL] [Abstract][Full Text] [Related]
11. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.
van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA
Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725
[TBL] [Abstract][Full Text] [Related]
12. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
13. c-kit gene mutation and CD117 expression in human anorectal melanomas.
Ni S; Huang D; Chen X; Huang J; Kong Y; Xu Y; Du X; Sheng W
Hum Pathol; 2012 Jun; 43(6):801-7. PubMed ID: 22154054
[TBL] [Abstract][Full Text] [Related]
14. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
15. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
16. KIT genetic alterations in anorectal melanomas.
Santi R; Simi L; Fucci R; Paglierani M; Pepi M; Pinzani P; Merelli B; Santucci M; Botti G; Urso C; Massi D
J Clin Pathol; 2015 Feb; 68(2):130-4. PubMed ID: 25398993
[TBL] [Abstract][Full Text] [Related]
17. Dark homogeneous streak dermoscopic pattern correlating with specific KIT mutations in melanoma.
Sanchez MI; Rabinovitz HS; Oliviero MC; Elgart GW; Perez C; Puig S; Malvehy J; Grichnik JM
JAMA Dermatol; 2014 Jun; 150(6):633-9. PubMed ID: 24695820
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of KIT mutations in melanoma: a meta-analysis.
Gong HZ; Zheng HY; Li J
Melanoma Res; 2018 Aug; 28(4):259-270. PubMed ID: 29746316
[TBL] [Abstract][Full Text] [Related]
19. KIT and Melanoma: Biological Insights and Clinical Implications.
Pham DDM; Guhan S; Tsao H
Yonsei Med J; 2020 Jul; 61(7):562-571. PubMed ID: 32608199
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Xia J; Jia P; Hutchinson KE; Dahlman KB; Johnson D; Sosman J; Pao W; Zhao Z
Mol Cancer Ther; 2014 Jul; 13(7):1918-28. PubMed ID: 24755198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
